The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-
term care of COVID-19 survivors. It is thus imperative to study post-COVID (ie, short-term) …

The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …

Background Thrombosis and inflammation may contribute to the risk of death and
complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized …

The novel corona virus infection (now classified as COVID-19), first identified in December
2019 in Wuhan, China, has contributed to significant mortality in several countries with the …

Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is
worrying, and the application of heparin in COVID‐19 has been recommended by some …

Coagulopathy in coronavirus infection has been shown to be associated with high mortality
with high D-dimers being a particularly important marker for the coagulopathy. 1 In the latest …

Abstract Severe coronavirus disease 2019 (COVID-19) is commonly complicated with
coagulopathy, the difference of coagulation features between severe pneumonia induced by …

Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The …

Coagulopathy in COVID-19 is a burning issue and strategies to prevent thromboembolic
events are debated and highly heterogeneous. The objective was to determine incidence …

Abstract Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than
1.8 million people worldwide, overwhelmed health care systems owing to the high …